Aggeliki Rapti

2.5k total citations
73 papers, 1.1k citations indexed

About

Aggeliki Rapti is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Oncology. According to data from OpenAlex, Aggeliki Rapti has authored 73 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Pulmonary and Respiratory Medicine, 23 papers in Physiology and 19 papers in Oncology. Recurrent topics in Aggeliki Rapti's work include Sarcoidosis and Beryllium Toxicity Research (16 papers), Lung Cancer Treatments and Mutations (16 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (13 papers). Aggeliki Rapti is often cited by papers focused on Sarcoidosis and Beryllium Toxicity Research (16 papers), Lung Cancer Treatments and Mutations (16 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (13 papers). Aggeliki Rapti collaborates with scholars based in Greece, Germany and China. Aggeliki Rapti's co-authors include Paul Zarogoulidis, Elias Gialafos, Sofia Lampaki, Nikolaos Katsikogiannis, Petros P. Sfikakis, Vasileios Kouranos, Νikolaos Koulouris, Anastasios Kallianos, Athol U. Wells and Konstantina Aggeli and has published in prestigious journals such as The Science of The Total Environment, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Aggeliki Rapti

68 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aggeliki Rapti Greece 20 717 303 283 167 158 73 1.1k
Amanda Roberts Canada 17 338 0.5× 129 0.4× 340 1.2× 289 1.7× 122 0.8× 46 1.2k
Sofia Lampaki Greece 23 640 0.9× 53 0.2× 200 0.7× 361 2.2× 187 1.2× 62 1.2k
Kazuhiko Fujii Japan 17 365 0.5× 230 0.8× 238 0.8× 126 0.8× 195 1.2× 63 921
Kwang‐Yoon Jung South Korea 22 231 0.3× 200 0.7× 335 1.2× 862 5.2× 264 1.7× 129 1.6k
Michael Gibbons United Kingdom 8 698 1.0× 118 0.4× 132 0.5× 134 0.8× 301 1.9× 38 1.3k
Skaidrius Miliauskas Lithuania 14 498 0.7× 190 0.6× 439 1.6× 78 0.5× 189 1.2× 67 1.0k
Kalpaj R. Parekh United States 23 669 0.9× 65 0.2× 152 0.5× 763 4.6× 217 1.4× 90 1.5k
Petri Toivanen Finland 9 201 0.3× 93 0.3× 69 0.2× 105 0.6× 92 0.6× 12 726
Koichi Honma Japan 18 613 0.9× 89 0.3× 94 0.3× 114 0.7× 94 0.6× 63 957
Alexander Gelbard United States 21 966 1.3× 525 1.7× 345 1.2× 284 1.7× 208 1.3× 104 1.7k

Countries citing papers authored by Aggeliki Rapti

Since Specialization
Citations

This map shows the geographic impact of Aggeliki Rapti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aggeliki Rapti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aggeliki Rapti more than expected).

Fields of papers citing papers by Aggeliki Rapti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aggeliki Rapti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aggeliki Rapti. The network helps show where Aggeliki Rapti may publish in the future.

Co-authorship network of co-authors of Aggeliki Rapti

This figure shows the co-authorship network connecting the top 25 collaborators of Aggeliki Rapti. A scholar is included among the top collaborators of Aggeliki Rapti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aggeliki Rapti. Aggeliki Rapti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kontsiotis, Vasileios J., Aggeliki Rapti, & Vasilios Liordos. (2022). Public attitudes towards venomous and non-venomous snakes. The Science of The Total Environment. 831. 154918–154918. 16 indexed citations
2.
Poulakou, Garyphalia, George Adamis, Aggeliki Rapti, et al.. (2022). Calprotectin and Imbalances between Acute-Phase Mediators Are Associated with Critical Illness in COVID-19. International Journal of Molecular Sciences. 23(9). 4894–4894. 18 indexed citations
3.
Koulouris, Νikolaos, Katerina Dimakou, Konstantinos I. Gourgoulianis, et al.. (2022). Self-perceived quality of sleep among COPD patients in Greece: the SLEPICO study. Scientific Reports. 12(1). 540–540. 6 indexed citations
4.
Aggeli, Constantina, Elias Gialafos, Vasileios Kouranos, et al.. (2018). Global longitudinal strain and long‐term outcomes in asymptomatic extracardiac sarcoid patients with no apparent cardiovascular disease. Echocardiography. 35(6). 804–808. 17 indexed citations
5.
Zarogoulidis, Paul, Anastasia Athanasiadou, Κonstantinos Porpodis, et al.. (2017). “Liquid elbows” due to afatinib administration. Respiratory Medicine Case Reports. 22. 64–66. 4 indexed citations
6.
Zarić, Bojan, Milana Panjković, Davorin Radosavljević, et al.. (2016). Clinicopathological features and relation between anaplastic lymphoma kinase (ALK) mutation and histological subtype of lung adenocarcinoma in Eastern European Caucasian population. Journal of Cancer. 7(15). 2207–2212. 4 indexed citations
7.
Syrigos, K., et al.. (2015). Cardiopulmonary exercise testing (CPET) as preoperative test before lung resection. World Allergy Organization Journal. 8(6). A22–A22. 21 indexed citations
8.
Kouranos, Vasileios, Aggeliki Rapti, Konstantina Aggeli, et al.. (2014). Predictors of cardiovascular events in newly diagnosed patients with sarcoidosis. European Respiratory Journal. 44(Suppl 58). P474–P474. 1 indexed citations
9.
Kouranos, Vasileios, George E. Tzelepis, Aggeliki Rapti, et al.. (2014). Diagnosis of cardiac sarcoidosis: A crossectional study in 327 consecutive patients. European Respiratory Journal. 44(Suppl 58). P463–P463. 1 indexed citations
10.
Spyratos, Dionysios, Paul Zarogoulidis, Κonstantinos Porpodis, et al.. (2013). Occupational exposure and lung cancer.. Europe PMC (PubMed Central). 5 Suppl 4. S440–5. 35 indexed citations
11.
Kallianos, Anastasios, Aggeliki Rapti, Andriani Charpidou, et al.. (2012). AB 17. Cardiopulmonary exercise testing (CPET) as preoperative test before lung resection. Journal of Thoracic Disease. 4(1).
12.
Kallianos, Anastasios, et al.. (2012). AB 28. Evaluation of pleural effusion at first diagnosis of lung cancer. Journal of Thoracic Disease. 4(1). 2 indexed citations
13.
Rapti, Aggeliki, Vasileios Kouranos, Elias Gialafos, et al.. (2012). Elevated Pulmonary Arterial Systolic Pressure in Patients with Sarcoidosis: Prevalence and Risk Factors. Lung. 191(1). 61–67. 30 indexed citations
14.
Papakosta, Despina, Georgia Pitsiou, Zoe Daniil, et al.. (2011). Prevalence of Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis: Correlation with Physiological Parameters. Lung. 189(5). 391–399. 28 indexed citations
15.
Makrythanasis, Periklis, Maria Tzetis, Aggeliki Rapti, et al.. (2010). Cystic Fibrosis Conductance Regulator, Tumor Necrosis Factor, Interferon Alpha-10, Interferon Alpha-17, and Interferon Gamma Genotyping as Potential Risk Markers in Pulmonary Sarcoidosis Pathogenesis in Greek Patients. Genetic Testing and Molecular Biomarkers. 14(4). 577–584. 6 indexed citations
16.
Gkiozos, Ioannis, et al.. (2010). Carboplatin Plus Pemetrexed as First-line Treatment of Patients With Malignant Pleural Mesothelioma: A Phase II Study. Clinical Lung Cancer. 11(1). 30–35. 45 indexed citations
17.
Makrythanasis, Periklis, Maria Tzetis, Joanne Traeger‐Synodinos, et al.. (2009). Association of TLR4 Single-Nucleotide Polymorphisms and Sarcoidosis in Greek Patients. Genetic Testing and Molecular Biomarkers. 13(6). 849–853. 6 indexed citations
18.
Moyssakis, Ioannis, Elias Gialafos, Nikolaοs Tentolouris, et al.. (2008). Impaired aortic elastic properties in patients with systemic sarcoidosis. European Journal of Clinical Investigation. 38(2). 82–89. 11 indexed citations
19.
Charpidou, Andriani, et al.. (2007). P2-243: A Phase II study of Carboplatin plus Pemetrexed in previously treated patients with non-small cell lung cancer (NSCLC). Journal of Thoracic Oncology. 2(8). S669–S669. 1 indexed citations
20.
Gazouli, Maria, John Ikonomopoulos, Elias Gialafos, et al.. (2006). CARD15/NOD2, CD14, and toll-like receptor 4 gene polymorphisms in Greek patients with sarcoidosis.. PubMed. 23(1). 23–9. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amanda Roberts Breakdown of academic impact, for papers by Sofia Lampaki Breakdown of academic impact, for papers by Kazuhiko Fujii Breakdown of academic impact, for papers by Kwang‐Yoon Jung Breakdown of academic impact, for papers by Michael Gibbons Breakdown of academic impact, for papers by Skaidrius Miliauskas Breakdown of academic impact, for papers by Kalpaj R. Parekh Breakdown of academic impact, for papers by Petri Toivanen Breakdown of academic impact, for papers by Koichi Honma Breakdown of academic impact, for papers by Alexander Gelbard
Rankless by CCL
2026